The corporate’s preliminary public providing contains a proposal for the sale of 4 crore fairness shares by the promoters and present traders.
The supply on the market contains as much as 1 crore shares by promoter Juneja household, as much as 2 crore shares by Capital Worldwide, as much as 99.65 lakh by Beige, and as much as 50,000 fairness shares by Hyperlink Funding Belief.
The ChrysCapital-backed consortium of
of Singapore and CPP Investments owns 10% of Mankind, whereas Capital Worldwide owns one other 11% stake.
The corporate has employed JM Morgan, Citi, Jefferies, Axis, IIFL, and Kotak as funding bankers.
The agency posted income of about Rs 8,000 crore and EBITDA of Rs 2,200 crore in FY22.
Mankind’s prime over-the-counter (OTC) manufacturers embrace being pregnant testing package Prega Information, emergency contraception Undesirable-21, AcneStar anti-bacterial gel, Ringout anti-fungal powder, Gasoline-O-Quick, Kaloree 1 synthetic sweetener, Heal-O-Sort anti-bacterial ointment, Dependancy Deodorant, and KabzEnd.
This shall be one of many largest public points by a home drug producer after the Rs 6,480-crore IPO of
in 2020. Macleods Prescription drugs has additionally filed to lift Rs 5,000 crore via an preliminary public providing (IPO), whereas Pune-based Emcure Pharma is planning a Rs 4,500-crore IPO.